Home
About Us
Seglin Technology
Programmes
Investors
News Centre
Careers
Contact Us
News Centre
Press Releases
Latest
2011
2010
2009
2008
2007
2006
2005
2004
Events
Home
...
News Centre
...
Press Releases
Press Releases
Tony Weir appointed as new Chief Financial Officer
Released 28th October 2008
Interim results for six months ended 31 July 2008
Released 28th October 2008
Zebrafish platform research agreement signed with Johnson & Johnson PTE Limited
Released 13th October 2008
Co-development agreement signed with the Lilly TB Drug Discovery Initiative
Released 7th October 2008
Co-development agreement signed with Orient Pharma in Sialorrhoea programme
Released 24th September 2008
Directorate change
Released 22nd August 2008
Worldwide licensing agreement signed with BioMarin for Duchenne muscular dystrophy programme
Released 22nd July 2008
Summit report progress in DMD programme at International conference
Released 29th April 2008
Positive results from Phase I clinical trial of SMT D002 for the treatment of acne
Released 15th April 2008
Summit Presents the Benefits Zebrafish Bring to Drug Discovery at International Conferences
Released 9th April 2008
£500,000 Contract Wins by Dextra Carbohydrate Service Business
Released 21st February 2008
Pre-close Trading Statement
Released 31st January 2008
SMT D002 Enters Phase II Clinical Trials for the treatment of sialorrhoea, a symptom of Parkinson's disease
Released 16th January 2008
